Neonatal Cardiovascular-Progenitor-Cell-Derived Extracellular Vesicles Activate YAP1 in Adult Cardiac Progenitor...

Area of Science:

• Cardiovascular Biology
• Regenerative Medicine
• Cellular Therapeutics

Background:

• Heart failure affects a growing patient population, necessitating novel therapeutic strategies.
• Neonatal cardiovascular progenitor cells (CPCs) exhibit superior regenerative capabilities compared to adult CPCs.
• Extracellular vesicles (EVs) are emerging as key mediators of intercellular communication and regenerative processes.

Purpose of the Study:

• To investigate the potential of EVs from neonatal human CPCs to enhance the regenerative capacity of adult human CPCs.
• To identify specific molecular mechanisms by which neonatal CPC-derived EVs influence adult CPC function.
• To assess the therapeutic implications of using neonatal CPC-derived EVs for cardiovascular repair.

Main Methods:

• Isolation of extracellular vesicles (EVs) from Islet-1+ expressing neonatal human CPCs.
• Comprehensive analysis of EV content using RNA sequencing (RNAseq).
• Co-culture of adult human CPCs with neonatal CPC-derived EVs to evaluate functional effects and transcriptomic changes.

Main Results:

• Treatment with neonatal CPC-derived EVs elevated AKT, ERBB, and YAP1 transcripts in adult CPCs.
• YAP1, a transcript crucial for cardiac regeneration and typically lost post-neonatally, was significantly upregulated.
• Neonatal CPC-derived EVs induced transcriptomic changes associated with enhanced cardiovascular regeneration and cell cycle activation in adult CPCs.

Conclusions:

• Neonatal CPC-derived EVs possess the potential to stimulate and improve the functional effects of adult CPCs.
• EV-mediated transfer of specific transcripts, such as YAP1, can confer enhanced regenerative properties to adult cardiovascular progenitor cells.
• This study highlights a promising cell-free therapeutic approach using neonatal EVs for cardiovascular repair in conditions like heart failure.